Prww: A Fast Track Through The FdaBy
A company that could somehow expedite the process of approval--or rejection--by the Food & Drug Administration could be a gigantic winner, says investment manager Jack Silver, president of SIAR Capital. He thinks such a company exists: PRWW (PRWW), which provides Web-based solutions that streamline the clinical-trial process for drugmakers.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.